Elucidating the role of cofactors in mammalian prion propagation

Prion

Volumn 8, Issue 1, 2014, Pages

  Supattapone, Surachai ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cofactors; Phosphatidylethanolamine; Phospholipids; Prion; RNA

Indexed keywords

NUCLEIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; POLYANION; PRION PROTEIN; PROTEIN X; RNA; PRION;

BRAIN HOMOGENATE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; GENE INACTIVATION; HAMSTER; HUMAN; IN VITRO STUDY; MAMMAL; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRION; PRION DISEASE; PROTEIN CONFORMATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; THERMOSTABILITY; VIRUS INFECTIVITY; WILD TYPE; ANIMAL; GENETICS; METABOLISM; PATHOGENICITY; VIRULENCE;

ANIMALS; CRICETINAE; PHOSPHATIDYLETHANOLAMINES; PRIONS; PRPSC PROTEINS; RNA; VIRULENCE;

EID: 84896906645     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.27501     Document Type: Review

References (34)

1. Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi. org/10.1073/pnas.95.23.13363
2. Raeber AJ, Borchelt DR, Scott M, Prusiner SB. Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems. J Virol 1992; 66:6155-63; PMID:1356161
3. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995; 375:698-700; PMID:7791905; http:// dx.doi.org/10.1038/375698a0
4. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471-4; PMID:7913989; http://dx.doi. org/10.1038/370471a0
5. Kocisko DA, Priola SA, Raymond GJ, Chesebro B, Lansbury PT Jr., Caughey B. Species specificity in the cell-free conversion of prion protein to proteaseresistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci U S A 1995; 92:3923- 7; PMID:7732006; http://dx.doi.org/10.1073/ pnas.92.9.3923
6. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810-3; PMID:11459061; http://dx.doi. org/10.1038/35081095
7. Castilla J, Saá P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell 2005; 121:195- 206; PMID:15851027; http://dx.doi.org/10.1016/j. cell.2005.02.011
8. Lucassen R, Nishina K, Supattapone S. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochemistry 2003; 42:4127-35; PMID:12680767; http://dx.doi. org/10.1021/bi027218d
9. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83:79-90; PMID:7553876; http://dx.doi. org/10.1016/0092- 8674(95)90236-8
10. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, Cohen FE, Prusiner SB. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A 1997; 94:10069-74; PMID:9294164; http://dx.doi. org/10.1073/pnas.94.19. 10069
11. Zulianello L, Kaneko K, Scott M, Erpel S, Han D, Cohen FE, Prusiner SB. Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J Virol 2000; 74:4351-60; PMID:10756050; http://dx.doi. org/10.1128/JVI.74.9.4351-4360.2000
12. Perrier V, Kaneko K, Safar J, Vergara J, Tremblay P, DeArmond SJ, Cohen FE, Prusiner SB, Wallace AC. Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci U S A 2002; 99:13079-84; PMID:12271119; http://dx.doi. org/10.1073/pnas.182425299
13. Lee CI, Yang Q, Perrier V, Baskakov IV. The dominant-negative effect of the Q218K variant of the prion protein does not require protein X. Protein Sci 2007; 16:2166-73; PMID:17766375; http://dx.doi. org/10.1110/ps.072954607
14. Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 2009; 5:e1000535; PMID:19649330; http://dx.doi.org/10.1371/ journal.ppat.1000535
15. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 2007; 104:9741- 6; PMID:17535913; http://dx.doi.org/10.1073/ pnas.0702662104
16. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 2005; 280:26873-9; PMID:15917229; http://dx.doi.org/10.1074/jbc.M503973200
17. Geoghegan JC, Valdes PA, Orem NR, Deleault NR, Williamson RA, Harris BT, Supattapone S. Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem 2007; 282:36341-53; PMID:17940287; http://dx.doi.org/10. 1074/jbc. M704447200
18. Nishina K, Deleault NR, Lucassen RW, Supattapone S. In vitro prion protein conversion in detergentsolubilized membranes. Biochemistry 2004; 43:2613- 21; PMID:14992599; http://dx.doi.org/10.1021/ bi035889l
19. Nishina KA, Deleault NR, Mahal SP, Baskakov I, Luhrs T, Riek R, Supattapone S. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. Biochemistry 2006; 45:14129-39; PMID:17115708; http://dx.doi. org/10.1021/bi061526k
20. Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 2009; 5:e1000421; PMID:19436715; http://dx.doi.org/10.1371/journal.ppat. 1000421
21. Wang F, Wang X, Ma J. Conversion of bacterially expressed recombinant prion protein. Methods 2011; 53:208-13; PMID:21176786; http://dx.doi. org/10.1016/j.ymeth.2010.12.013
22. Castilla J, Morales R, Saá P, Barria M, Gambetti P, Soto C. Cell-free propagation of prion strains. EMBO J 2008; 27:2557-66; PMID:18800058; http://dx.doi. org/10.1038/emboj.2008.181
23. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S. Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 2010; 49:3928- 34; PMID:20377181; http://dx.doi.org/10.1021/ bi100370b
24. Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 2012; 109:8546-51; PMID:22586108; http://dx.doi.org/10.1073/ pnas.1204498109
25. Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, Ma J, Rees JR, Supattapone S. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A 2012; 109:E1938-46; PMID:22711839; http:// dx.doi.org/10.1073/pnas.1206999109
26. Bruce ME. Scrapie strain variation and mutation. Br Med Bull 1993; 49:822-38; PMID:8137131
27. Carlson GA. Prion strains. Curr Top Microbiol Immunol 1996; 207:35-47; PMID:8575205; http:// dx.doi.org/10.1007/978-3-642-60983-1-4
28. Piro JR, Harris BT, Nishina K, Soto C, Morales R, Rees JR, Supattapone S. Prion protein glycosylation is not required for strain-specific neurotropism. J Virol 2009; 83:5321-8; PMID:19297485; http://dx.doi. org/10.1128/JVI.02502-08
29. Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132-5; PMID:20110469; http:// dx.doi.org/10.1126/science.1183748
30. Saá P, Sferrazza GF, Ottenberg G, Oelschlegel AM, Dorsey K, Lasmézas CI. Strain-specific role of RNAs in prion replication. J Virol 2012; 86:10494- 504; PMID:22811520; http://dx.doi.org/10.1128/ JVI.01286-12
31. Gonzalez-Montalban N, Lee YJ, Makarava N, Savtchenko R, Baskakov IV. Changes in prion replication environment cause prion strain mutation. FASEB J 2013; 27:3702-10; PMID:23729586; http://dx.doi.org/10.1096/fj.13-230466
32. Fernández-Borges N, Eraña H, Elezgarai SR, Harrathi C, Gayosso M, Castilla J. Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism. Int J Cell Biol 2013; 2013:583498; PMID:24187553; http://dx.doi. org/10.1155/2013/583498
33. Brown P, Gibbs CJ Jr., Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35:513-29; PMID:8179297; http://dx.doi. org/10.1002/ana. 410350504
34. Brown P, Prece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55:1075- 81; PMID:11071481; http://dx.doi.org/10. 1212/ WNL.55.8.1075